Pfizer
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $14,653,000 | $13,715,000 | $17,763,000 | $17,702,000 |
Gross Profit | 9,420,000 | 9,827,000 | 12,968,000 | 10,771,000 |
EBITDA | 5,323,000 | 5,056,000 | 5,143,000 | 7,253,000 |
EBIT | 3,698,000 | 3,438,000 | 3,352,000 | 5,498,000 |
Net Income | 2,910,000 | 2,967,000 | 403,000 | 4,473,000 |
Net Change In Cash | 14,653,000 | 13,715,000 | 17,763,000 | 17,702,000 |
Free Cash Flow | -1,200,000 | 1,771,000 | 5,804,000 | 6,063,000 |
Cash | 1,638,000 | 1,430,000 | 1,043,000 | 1,092,000 |
Basic Shares | 5,706,000 | 5,710,000 | 5,703,000 | 5,705,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $63,627,000 | $59,553,000 | $100,330,000 | $81,288,000 |
Gross Profit | 41,846,000 | 30,340,000 | 62,090,000 | 46,875,000 |
EBITDA | 18,127,000 | 9,557,000 | 41,031,000 | 30,793,000 |
EBIT | 11,114,000 | 3,267,000 | 35,967,000 | 25,602,000 |
Net Income | 8,020,000 | 2,133,000 | 31,365,000 | 22,147,000 |
Net Change In Cash | 63,627,000 | 59,553,000 | 100,330,000 | 81,288,000 |
Cost of Revenue | -1,350,000 | 218,000 | ||
Free Cash Flow | 9,835,000 | 4,793,000 | 26,031,000 | 29,869,000 |
Cash | 1,043,000 | 2,853,000 | 416,000 | 1,944,000 |
Basic Shares | 5,700,000 | 5,709,000 | 5,733,000 | 5,708,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0.51 |
2025-03-31 | $0.92 |
2024-12-31 | $0.63 |
2024-09-30 | $1.06 |
